Zhiben Medical Technology (Shanghai) Co. Ltd. (doing business as OrigiMed) is a company headquartered in Shanghai, China. The firm develops medical science and technology transforming application. It was founded in 2016.\nThe company says this about itself: OrigiMed is a precision medicine company focusing on high-tech R&D with a global vision and the knowledge transfer in the clinical practice of cancers. With the commitment to developing hundreds of cancer genomic tests, the company strive to provide comprehensive and accurate molecular information to every patient and help doctors with their precision medicine practice. OrigiMed aims to promote the innovation in the way of clinical treatment for cancer in China. At OrigiMed, patients' molecular changes are identified by the stringently verified CGP and matched with approved targeted therapies, immunotherapies, and clinical trials. OrigiMed closely collaborates with global and domestic biopharmaceutical companies to help with new drug development and approvals.

Guangzhou Jinyu Translational Medicine Research Institute Co., Ltd., established on 2016-07-20, Business scope includes research in health science projects,to develop;Medical Research and Experimental Development;Gene drug development;Technology Promotion of Research Results of Health Science Projects;Biotechnology Extension Services;

Jiangsu Medical Union Biotechnology Co., Ltd., established on 2016-04-13, Business scope includes licensed projects:medical service;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Medical Research and Experimental Development;Sales of Class I Medical Devices;Production of Class I Medical Devices;Information security equipment sales;New material technology promotion service;Artificial intelligence theory and algorithm software development;Engineering and Technology Research and Experimental Development;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Paisenuo Gene Technology Co., Ltd., established on 2017-08-31, Business scope includes licensed projects:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export;Import and export agency;Health Consulting Services(Does not include medical services);software development;Manufacturing of experimental analysis instruments;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Ronglian Group Ltd. engages in design, development, and sale of information technology systems. It provides data center and information technology infrastructure solutions, cloud computing, enterprise mobile applications, software development, business consulting and other professional services. The company was founded by Dong Hui Wang on March 12, 2001 and is headquartered in Beijing, China.

Gooal Gene operates as an ag-biotechnology company. Gooal Gene is a high-tech research and development center with high-throughput sequencing of second and third generation, bioinformatics analysis, interactive analysis report, multi-omics knowledge base and genome selection breeding platform.

Guangzhou Jinyuda Logistics Co., Ltd., established on 2015-08-19, Business scope includes loading and unloading;International Freight Forwarder;Medical Equipment Repair;Medical equipment rental service;Other warehousing(Does not contain crude oil,Refined oil storage,Gas Storage,Dangerous goods storage);Cargo inspection agency service;Air Freight Forwarding Services;Electronics retail;business franchise;Medical supplies and equipment retail(Does not contain drugs and medical devices);Cargo customs declaration agency service;Bale,loading and unloading,Shipping full service agency;Logistics agency service;Operation of non-licensed medical devices;road freight forwarder;Warehousing agency service;for medical devices,equipment,Professional cleaning of medical and sanitary materials and supplies,Disinfection and Sterilization;Transport cargo packing service;Sales of packaging materials;Information Technology Consulting Services;Wholesale of electronic products;Import and export(Excluding franchised products);Technology Import and Export;Information system integration service;Engineering Management Services;Engineering technical service(planning management,survey,design,Except supervision);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Provide medical device storage and distribution services;medical diagnosis,Monitoring and treatment equipment wholesale;Licensed medical device business;road freight transport;Dedicated transport of goods(Refrigerated);Blood product management;Freight Terminal Services;General cargo transportation(Moving transportation service);collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage)

Integrated DNA Technologies sells short strands of DNA called oligonucleotides. In order to better understand how these are useful, you'll have to know a bit about DNA itself. DNA is "the blueprint for life" and encodes instructions for all of life's processes. DNA is a complex long thin molecule (strand) that is made from 4 possible building blocks called "bases". These bases are called Adenine, Cytosine, Guanine and Thymine, and the precise order of these bases is a code for information. In living organisms, DNA strands can be millions of bases long and therefore contain huge amounts of information. This complexity is responsible for the vast complexity and diversity of life on earth. The way that one strand of DNA specifically binds a second strand of DNA allows scientists to use short DNA strands (oligos) as research tools. A short synthetic piece of DNA (usually around 20 bases long) can be used to bind or find its matching sequence even in a complex mixture of millions of unrelated pieces of DNA. It is this unique fact that allows researchers to decode and study the genetic makeup of any living organism. Using new oligo-based technologies, a revolution is underway where they are beginning to catalog the complete genetic makeup of hundreds of living things, ranging from bacteria to humans. The human genome alone contains over 3 billion bases of DNA, so projects of this kind tend to be very complex and often take years to complete. Scientists often start the research knowing the DNA sequence for the organism that they are interested in studying. Given a known DNA sequence, they can easily design a short oligo that can be used to perform a variety of tasks. It is this short single-stranded DNA that the researcher orders from IDT. Living systems don't discriminate DNA that is synthesized chemically from DNA taken directly from an organism, allowing researchers to use IDT's custom made oligonucleotides as if they had existed naturally. IDT manufactures the oligo using chemical DNA synthesis machines designed and built in-house. They've refined the process to the point where they can receive an order as late as 1:00pm and have the desired oligo in the researcher's hands the next morning. Their customers range from small university labs of only a few scientists to global pharmaceutical companies, and everything in between.

Sanbo Ruiyuan Technology Co., Ltd., established on 2021-08-02, Business scope includes general items:Artificial intelligence industry application system integration service;Artificial intelligence innovation and innovation service platform;Artificial intelligence application software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Retailing of computer software, hardware and auxiliary equipment;Computer System Services;software development;data processing services;Instrument Manufacturing;Research and development of bio-based materials technology(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL.

Suzhou Basecare Medical Device Co. Ltd. is a Chinese company located in Suzhou. The firm manufactures and wholesales medical devices for chromosomal abnormalities. It was founded in 2015.

Shanghai Zhiben Medical Laboratory Co., Ltd., established on 2017-05-04, Business scope includes for-profit medical institutions,Engaged in the field of biotechnology and a class,Class II,Technology development of three types of medical devices,technology transfer,technical consulting,Technical Services,one type,Class II,Class III Medical Devices,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangzhou Kingmed Center For Clinical Laboratory Co., Ltd. provides clinical and laboratory testing services. It offers clinical trials, medical examination, food and hygiene testing, physical examination, scientific research services, and quality management. The company was founded by YaoMing Liang in 1994 and is headquartered in Guangzhou, China.

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help their clients realize their research goals in the rapidly evolving world of genomics. The company has become a world-leader in NGS services, with 1,800 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 49 NGS-related patents, as well as the publishing of over 1850 customer research papers, often in well-respected publications such as Nature and Science. Company founder, Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 12 patents and authoring over 90 peer-reviewed publications that have been cited >15,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND providing informatics to fully empower and enable their customers to move forward rapidly and effectively in their scientific endeavors.

Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The genetic testing includes medical products and services, and basic research services. Medical products and services are divided into medical testing services, reagent sales, and equipment sales. Medical testing services are mainly divided into two applications: genetics and oncology. The company was founded on April 14, 1997 and is headquartered in Beijing, China.